Search Results - "AIBL"

Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.

Authors: Lim, Yen Ying Ellis, KathrynA. Harrington, Karra et al.

Source: Journal of Clinical & Experimental Neuropsychology. Apr2012, Vol. 34 Issue 4, p345-358. 14p.

Subjects: Cognitive testing, Mild cognitive impairment, Alzheimer's disease, Biomarkers, Apolipoprotein E

Geographic Terms: Australia

Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline.

Authors: Ayton, Scott Fazlollahi, Amir Bourgeat, Pierrick et al.

Source: Brain: A Journal of Neurology; Aug2017, Vol. 140 Issue 8, p2112-2119, 8p

Amyloid burden and incident depressive symptoms in cognitively normal older adults.

Authors: Harrington, Karra D. Gould, Emma Lim, Yen Ying et al.

Source: International Journal of Geriatric Psychiatry. Apr2017, Vol. 32 Issue 4, p455-463. 9p.

Subjects: Amyloid, Depression in old age, Mental depression, Alzheimer's disease, Senile dementia

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.

Authors: Lim, Yen Ying Maruff, Paul Pietrzak, Robert H et al.

Source: Brain: A Journal of Neurology; Jan2014, Vol. 137 Issue 1, p221-231, 11p

Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.

Authors: Foster, Jonathan K Albrecht, Matthew A Savage, Greg et al.

Source: Brain: A Journal of Neurology; Jul2013, Vol. 136 Issue 7, p2201-2216, 16p

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Authors: Villain N Chételat G Grassiot B et al.

Source: Brain: A Journal of Neurology; Jul2012, Vol. 135 Issue 7, p2126-2139, 14p

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Authors: Chételat G Villemagne VL Pike KE et al.

Source: Brain: A Journal of Neurology; Mar2011, Vol. 134 Issue 3, p798-807, 10p

Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults.

Authors: Gardener, Samantha L. Weinborn, Michael Sohrabi, Hamid R. et al.

Source: Journal of Alzheimer's Disease. 2021, Vol. 81 Issue 3, p1039-1052. 14p.

Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.

Authors: Xia, Ying Yassi, Nawaf Raniga, Parnesh et al.

Source: Journal of Alzheimer's Disease. 2020, Vol. 78 Issue 1, p321-334. 14p.

Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.

Authors: Lim, Wei Ling Florence Huynh, Kevin Chatterjee, Pratishtha et al.

Source: Journal of Alzheimer's Disease. 2020, Vol. 76 Issue 1, p303-315. 13p.

Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.

Authors: Dang, Christa Harrington, Karra D Lim, Yen Ying et al.

Source: Archives of Clinical Neuropsychology. Jul2019, Vol. 34 Issue 5, p585-598. 14p.

Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.

Authors: Porter, Tenielle Burnham, Samantha C. Milicic, Lidija et al.

Source: Journal of Alzheimer's Disease. 2018, Vol. 66 Issue 3, p1193-1211. 19p.

Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.

Authors: Dang, Christa Harrington, Karra D. Lim, Yen Ying et al.

Source: Journal of Alzheimer's Disease. 2018, Vol. 65 Issue 4, p1313-1325. 13p.

Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.

Authors: Perin, Stephanie Harrington, Karra D. Lim, Yen Ying et al.

Source: Journal of Affective Disorders. Mar2018, Vol. 229, p269-274. 6p.

Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.

Authors: Yen Ying Lim Williamson, Robert Laws, Simon M. et al.

Source: Journal of Alzheimer's Disease. 2017, Vol. 58 Issue 4, p1293-1302. 10p.

Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner.

Authors: Gardener, Samantha L. Rainey-Smith, Stephanie R. Sohrabi, Hamid R. et al.

Source: Journal of Alzheimer's Disease. 2017, Vol. 58 Issue 1, p193-201. 9p.

APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.

Authors: Hollands, Simone Yen Ying Lim Laws, Simon M. et al.

Source: Journal of Alzheimer's Disease. 2017, Vol. 57 Issue 2, p411-422. 12p.

Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL).

Authors: Cardoso, Bárbara R. Hare, Dominic J. Bush, Ashley I. et al.

Source: Journal of Alzheimer's Disease. 2017, Vol. 57 Issue 1, p183-193. 11p. 1 Diagram, 1 Chart, 4 Graphs.

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.

Authors: Burnham, Samantha C Bourgeat, Pierrick Doré, Vincent et al.

Source: Lancet Neurology. Sep2016, Vol. 15 Issue 10, p1044-1053. 10p.

Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.

Authors: Burnham, Samantha C Raghavan, Nandini Wilson, William et al.

Source: Journal of Alzheimer's Disease. 2015, Vol. 46 Issue 4, p1079-1089. 11p.